BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
62.74
+0.80 (1.29%)
Apr 24, 2025, 4:00 PM EDT - Market closed
BioMarin Pharmaceutical Analyst Ratings
Total Analysts
22
Consensus Rating
Buy
Price Target
$94.00
Upside
+49.82%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $98 | Hold → Buy | Upgrades | $98 | +56.20% | Feb 24, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $78 → $80 | Hold | Maintains | $78 → $80 | +27.51% | Feb 20, 2025 |
| Citigroup | Citigroup | Hold Maintains $81 → $82 | Hold | Maintains | $81 → $82 | +30.70% | Feb 20, 2025 |
| RBC Capital | RBC Capital | Hold Reiterates $70 | Hold | Reiterates | $70 | +11.57% | Feb 20, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $90 | Buy | Reiterates | $90 | +43.45% | Feb 20, 2025 |
| UBS | UBS | Strong Buy Maintains $109 → $113 | Strong Buy | Maintains | $109 → $113 | +80.11% | Feb 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $122 → $126 | Buy | Maintains | $122 → $126 | +100.83% | Feb 20, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $99 → $103 | Strong Buy | Maintains | $99 → $103 | +64.17% | Feb 20, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $90 | Buy | Reiterates | $90 | +43.45% | Dec 12, 2024 |
| Wolfe Research | Wolfe Research | Buy Initiates $95 | Buy | Initiates | $95 | +51.42% | Nov 15, 2024 |
| Citigroup | Citigroup | Hold Maintains $93 → $81 | Hold | Maintains | $93 → $81 | +29.10% | Oct 30, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $93 → $84 | Hold | Maintains | $93 → $84 | +33.89% | Oct 30, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $110 → $90 | Buy | Maintains | $110 → $90 | +43.45% | Oct 30, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $110 → $109 | Buy | Maintains | $110 → $109 | +73.73% | Oct 30, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $80 | Hold | Reiterates | $80 | +27.51% | Oct 30, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $115 → $105 | Buy | Maintains | $115 → $105 | +67.36% | Oct 30, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.